Table 1. Characteristics of the included case-control studies on the MTHFR C677T polymorphism in cervical lesions.
Firstauthor[reference] | Year | Sourceofcontrol | SourceofDNA | Country | Ethnicity | HWE | Histology | Samplesize | Case | Control | |||||||||||
case | control | C | T | CC | CT | TT | CT+TT | C | T | CC | CT | TT | CT+TT | ||||||||
Prasad [20] | 2011 | Mixed | Blood | India | Asian | NS | ICC | 62 | 125 | 119 | 5 | 57 | 5 | 0 | 5 | 240 | 10 | 116 | 8 | 1 | 9 |
Mostowska [21] | 2011 | Healthy persons | Blood | Poland | Caucasian | NS | ICC | 124 | 168 | 194 | 77 | 56 | 59 | 9 | 68 | 219 | 117 | 69 | 81 | 18 | 99 |
Tong [26] | 2011 | Healthy persons | Blood | Korea | Asian | NS | LSIL | 159 | 427 | 186 | 132 | 52 | 82 | 25 | 107 | 502 | 352 | 152 | 198 | 77 | 275 |
HSIL | 160 | 427 | 182 | 138 | 54 | 74 | 32 | 106 | 502 | 352 | 152 | 198 | 77 | 275 | |||||||
ICC | 146 | 427 | 171 | 121 | 53 | 65 | 28 | 93 | 502 | 352 | 152 | 198 | 77 | 275 | |||||||
Kohaar [22] | 2010 | Healthy persons | Tissue or cell | India | Asian | NS | HSIL | 39 | 231 | 67 | 11 | 28 | 11 | 0 | 11 | 387 | 75 | 161 | 65 | 5 | 70 |
ICC | 164 | 231 | 273 | 55 | 113 | 47 | 4 | 51 | 387 | 75 | 161 | 65 | 5 | 70 | |||||||
Shekari [32] | 2008 | Healthy persons | Blood | India | Asian | NS | ICC | 200 | 200 | 368 | 32 | 170 | 28 | 2 | 30 | 318 | 82 | 125 | 68 | 7 | 75 |
Nandan [27] | 2008 | Healthy persons | Blood | India | Asian | NA | SIL | 80 | 77 | NA | NA | 34 | NA | NA | 46 | NA | NA | 53 | NA | NA | 24 |
ICC | 62 | 77 | NA | NA | 36 | NA | NA | 26 | NA | NA | 53 | NA | NA | 24 | |||||||
Piyathilake [33] | 2007 | Mixed | Blood | USA | Mixed | NS | HSIL | 80 | 355 | 134 | 26 | 59 | 16 | 5 | 21 | 562 | 148 | 223 | 116 | 16 | 132 |
Zoodsma [34] | 2005 | Mixed | Blood | Netherlands | Caucasian | NS | HSIL | 264 | 592 | 362 | 166 | 121 | 120 | 23 | 143 | 808 | 376 | 273 | 262 | 57 | 319 |
ICC | 636 | 592 | 944 | 328 | 357 | 230 | 49 | 279 | 808 | 376 | 273 | 262 | 57 | 319 | |||||||
Kang [23] | 2005 | Healthy persons | Blood | Korean | Asian | NS | ICC | 79 | 74 | 86 | 72 | 27 | 32 | 20 | 52 | 92 | 56 | 30 | 32 | 12 | 44 |
Sull [28] | 2004 | Healthy persons | Blood | Korean | Asian | NS | LSIL | 40 | 454 | 42 | 38 | 10 | 22 | 8 | 30 | 527 | 381 | 153 | 221 | 80 | 301 |
HSIL | 176 | 454 | 190 | 162 | 50 | 90 | 36 | 126 | 527 | 381 | 153 | 221 | 80 | 301 | |||||||
ICC | 246 | 454 | 261 | 231 | 73 | 115 | 58 | 173 | 527 | 381 | 153 | 221 | 80 | 301 | |||||||
Lambropoulos [24] | 2003 | Healthy persons | Tissue or cell | Greece | Caucasian | NS | LSIL | 53 | 91 | 68 | 38 | 20 | 28 | 5 | 33 | 121 | 61 | 42 | 37 | 12 | 49 |
HSIL | 64 | 91 | 83 | 45 | 27 | 29 | 8 | 37 | 121 | 61 | 42 | 37 | 12 | 49 | |||||||
ICC | 21 | 91 | 30 | 12 | 11 | 8 | 2 | 10 | 121 | 61 | 42 | 37 | 12 | 49 | |||||||
Goodman [29] | 2001 | Hospital patients | Blood | USA | Mixed | NS | SIL | 150 | 179 | 213 | 87 | 73 | 67 | 10 | 77 | 261 | 97 | 93 | 75 | 11 | 86 |
Piyathilake [30] | 2000 | Healthy persons | Tissue or cell | USA | Mixed | NS | LSIL | 25 | 31 | 25 | 25 | 6 | 13 | 6 | 19 | 44 | 18 | 16 | 12 | 3 | 15 |
HSIL | 39 | 31 | 45 | 33 | 11 | 23 | 5 | 28 | 44 | 18 | 16 | 12 | 3 | 15 | |||||||
Agodi [35] | 2010 | Healthy persons | Cell | Italy | Caucasian | NA | SIL | 123 | 66 | NA | NA | 118 | NA | NA | 5 | NA | NA | 55 | NA | NA | 11 |
Yang [25] | 2011 | Mixed | Blood | China | Asian | NS | SIL | 38 | 382 | 60 | 16 | 23 | 14 | 1 | 15 | 530 | 234 | 182 | 166 | 34 | 200 |
ICC | 157 | 382 | 229 | 85 | 77 | 75 | 5 | 80 | 530 | 234 | 182 | 166 | 34 | 200 | |||||||
Ma [31] | 2006 | Hospital patients | Blood | China | Asian | NS | ICC | 111 | 111 | 93 | 129 | 20 | 53 | 38 | 91 | 126 | 96 | 33 | 60 | 18 | 78 |
Abbreviations: HWE, Hardy-Weinberg Equilibrium; NA, not available; NS, not significant; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; ICC, invasive cervical cancer; SIL, squamous intra-epithelial lesion.